Cargando…

Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis

Neuroblastoma (NB) is the most common extracranial childhood tumor classified in five stages (1, 2, 3, 4 and 4S), two of which (3 and 4) identify chemotherapy-resistant, highly aggressive disease. High-risk NB frequently displays MYCN amplification, mutations in ALK and ATRX, and genomic rearrangeme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolai, S, Pieraccioli, M, Peschiaroli, A, Melino, G, Raschellà, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720889/ https://www.ncbi.nlm.nih.gov/pubmed/26633716 http://dx.doi.org/10.1038/cddis.2015.354

Ejemplares similares

ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma
por: Pieraccioli, Marco, et al.
Publicado: (2018)

ZNF281 is recruited on DNA breaks to facilitate DNA repair by non-homologous end joining
por: Nicolai, Sara, et al.
Publicado: (2019)

Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia
por: Huang, Xianbo, et al.
Publicado: (2018)

New factors in mammalian DNA repair—the chromatin connection
por: Raschellà, G, et al.
Publicado: (2017)

ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment
por: Gatti, Veronica, et al.
Publicado: (2019)

Exploitation of necroptosis for treatment of caspase-compromised cancers
por: Cho, Young Sik, et al.
Publicado: (2017)

ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Nicolai, Sara, et al.
Publicado: (2019)

DNA repair and aging: the impact of the p53 family
por: Nicolai, Sara, et al.
Publicado: (2015)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors
por: Bielli, Pamela, et al.
Publicado: (2019)

Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
por: Beretta, Giovanni Luca, et al.
Publicado: (2022)

ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications
por: Chen, Xin-yu, et al.
Publicado: (2022)

Necroptosis in Organ Transplantation: Mechanisms and Potential Therapeutic Targets
por: Zhao, Yajin, et al.
Publicado: (2023)

Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
por: Zhang, Ruxin, et al.
Publicado: (2023)

Challenging tumor resistance with less toxic, more effective drug combinations: an example from neuroblastoma
por: Gambacurta, Alessandra, et al.
Publicado: (2018)

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target
por: Chen, Jing, et al.
Publicado: (2019)

The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
por: Gatti, Veronica, et al.
Publicado: (2020)

Senataxin and R-loops homeostasis: multifaced implications in carcinogenesis
por: Gatti, Veronica, et al.
Publicado: (2023)

Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators
por: Seo, Jinho, et al.
Publicado: (2021)

Mitochondrial Mechanisms of Necroptosis in Liver Diseases
por: Xue, Chen, et al.
Publicado: (2020)

ΔNp63α modulates histone methyl transferase SETDB1 to transcriptionally repress target genes in cancers
por: Regina, C, et al.
Publicado: (2016)

Necroptosis in neurodegenerative diseases: a potential therapeutic target
por: Zhang, Shuo, et al.
Publicado: (2017)

Targeting necroptosis as therapeutic potential in chronic myocardial infarction
por: Piamsiri, Chanon, et al.
Publicado: (2021)

Development of a prognostic model for children with neuroblastoma based on necroptosis-related genes
por: Jing Chu,
Publicado: (2022)

The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
por: Huang, Shaohui, et al.
Publicado: (2022)

Mechanisms of necroptosis in T cells
por: Ch’en, Irene L., et al.
Publicado: (2011)

Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases
por: Tang, Lu, et al.
Publicado: (2023)

Targeting lipid metabolism in cancer: neuroblastoma
por: Agostini, Massimiliano, et al.
Publicado: (2022)

p63 at the Crossroads between Stemness and Metastasis in Breast Cancer
por: Gatti, Veronica, et al.
Publicado: (2019)

Characterizing the prognostic and therapeutic value of necroptosis in sarcoma based on necroptosis subtypes
por: Ma, Yibo, et al.
Publicado: (2022)

Targeting necroptosis in anticancer therapy: mechanisms and modulators
por: Wu, Ying, et al.
Publicado: (2020)

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Linc01105 acts as an oncogene in the development of neuroblastoma
por: Ye, Mujie, et al.
Publicado: (2021)

Necroptosis in Cholangiocarcinoma
por: Sarcognato, Samantha, et al.
Publicado: (2020)

Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs
por: Ciaccio, Roberto, et al.
Publicado: (2021)

Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers
por: Karami Fath, Mohsen, et al.
Publicado: (2022)

Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives
por: Negroni, Anna, et al.
Publicado: (2020)

Potential therapeutic value of necroptosis inhibitor for the treatment of COVID-19
por: Kang, Yongan, et al.
Publicado: (2022)

Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e9607taovq1diljfcm5ncml8rr